Smoking Cessation Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Drug therapy, E-cigarettes, Nicotine replacement therapies, and Nicotine Sublingual tablets); Distribution (Drug stores, Hospital pharmacies, Online pharmacies, and Retail pharmacies)
Report Code: TIPRE00029337 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET OVERVIEW
Smoking cessation medications are anti-addiction medications. Nicotine, an alkaloid compound, causes addictive dependence on cigarettes and other smoking products. Smoking cessation medications are anti-addiction medications. After quitting smoking, a person may experience withdrawal symptoms such as anxiety, strong cravings, a depressed mood, insomnia, and mood changes. With rising smoking addictions, a high prevalence of smoking-related diseases, and anti-smoking campaigns promoting smoking cessation drugs, the global smoking cessation drugs market is booming.
MARKET SCOPE
The Smoking Cessation Drugs Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Smoking Cessation Drugs Market with detailed market segmentation by Product, Distribution, and geography. The report provides key statistics on the market status of the leading Smoking Cessation Drugs Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Smoking Cessation Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Smoking Cessation Drugs Market in these regions.
IMPACT OF COVID-19 ON SMOKING CESSATION DRUG MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic.
The report covers key developments in the Smoking Cessation Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players in the Smoking Cessation Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Smoking Cessation Drugs Market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Smoking Cessation Drugs Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
Smoking cessation medications are anti-addiction medications. Nicotine, an alkaloid compound, causes addictive dependence on cigarettes and other smoking products. Smoking cessation medications are anti-addiction medications. After quitting smoking, a person may experience withdrawal symptoms such as anxiety, strong cravings, a depressed mood, insomnia, and mood changes. With rising smoking addictions, a high prevalence of smoking-related diseases, and anti-smoking campaigns promoting smoking cessation drugs, the global smoking cessation drugs market is booming.
MARKET SCOPE
The Smoking Cessation Drugs Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Smoking Cessation Drugs Market with detailed market segmentation by Product, Distribution, and geography. The report provides key statistics on the market status of the leading Smoking Cessation Drugs Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on Product, the Smoking Cessation Drugs Market is segmented into Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets
- Based on Distribution, the market is segmented into Drug stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
MARKET DYNAMICS
Drivers:
- An increasing number of smokers and stringent laws for smoking such as a ban on smoking in a public places are fuelling the market growth.
- The reimbursements policies for smoking cessation drug therapies, anti-smoking programs by WHO such as the 'Tobacco Free Initiative'
- Increasing consciousness and education among the young population and smokers.
- A strict regulatory requirement for an electronic cigarette as a medical device is restraining the market growth.
- The high cost of smoking cessation drugs, adverse reactions, and smoking relapse.
- Lack of mass acceptance, and less awareness of smoking cessation drugs are hampering the smoking cessation drugs market growth.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Smoking Cessation Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Smoking Cessation Drugs Market in these regions.
IMPACT OF COVID-19 ON SMOKING CESSATION DRUG MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic.
The report covers key developments in the Smoking Cessation Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players in the Smoking Cessation Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Smoking Cessation Drugs Market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Smoking Cessation Drugs Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
- British American Tobacco PLC
- Dr. Reddy's Laboratories
- Fontem Ventures
- GlaxoSmithKline
- GSK
- Imperial Tobacco
- Johnson & Johnson
- Kimree Technology
- Nicotek LLC
- Njoy Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Smoking Cessation Drugs Market - By Product
1.3.2 Smoking Cessation Drugs Market - By Distribution
1.3.3 Smoking Cessation Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMOKING CESSATION DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMOKING CESSATION DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMOKING CESSATION DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. SMOKING CESSATION DRUGS - GLOBAL MARKET OVERVIEW
6.2. SMOKING CESSATION DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DRUG THERAPY
7.3.1. Overview
7.3.2. Drug therapy Market Forecast and Analysis
7.4. E-CIGARETTES
7.4.1. Overview
7.4.2. E-cigarettes Market Forecast and Analysis
7.5. NICOTINE REPLACEMENT THERAPIES
7.5.1. Overview
7.5.2. Nicotine replacement therapies Market Forecast and Analysis
7.6. AND NICOTINE SUBLINGUAL TABLETS.
7.6.1. Overview
7.6.2. and Nicotine Sublingual tablets. Market Forecast and Analysis
8. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION
8.1. OVERVIEW
8.2. DISTRIBUTION MARKET FORECASTS AND ANALYSIS
8.3. DRUG STORES
8.3.1. Overview
8.3.2. Drug stores Market Forecast and Analysis
8.4. HOSPITAL PHARMACIES
8.4.1. Overview
8.4.2. Hospital pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online pharmacies Market Forecast and Analysis
8.6. AND RETAIL PHARMACIES.
8.6.1. Overview
8.6.2. and Retail pharmacies. Market Forecast and Analysis
9. SMOKING CESSATION DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Smoking Cessation Drugs Market Overview
9.1.2 North America Smoking Cessation Drugs Market Forecasts and Analysis
9.1.3 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.1.5 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Smoking Cessation Drugs Market
9.1.5.1.1 United States Smoking Cessation Drugs Market by Product
9.1.5.1.2 United States Smoking Cessation Drugs Market by Distribution
9.1.5.2 Canada Smoking Cessation Drugs Market
9.1.5.2.1 Canada Smoking Cessation Drugs Market by Product
9.1.5.2.2 Canada Smoking Cessation Drugs Market by Distribution
9.1.5.3 Mexico Smoking Cessation Drugs Market
9.1.5.3.1 Mexico Smoking Cessation Drugs Market by Product
9.1.5.3.2 Mexico Smoking Cessation Drugs Market by Distribution
9.2. EUROPE
9.2.1 Europe Smoking Cessation Drugs Market Overview
9.2.2 Europe Smoking Cessation Drugs Market Forecasts and Analysis
9.2.3 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.2.5 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Smoking Cessation Drugs Market
9.2.5.1.1 Germany Smoking Cessation Drugs Market by Product
9.2.5.1.2 Germany Smoking Cessation Drugs Market by Distribution
9.2.5.2 France Smoking Cessation Drugs Market
9.2.5.2.1 France Smoking Cessation Drugs Market by Product
9.2.5.2.2 France Smoking Cessation Drugs Market by Distribution
9.2.5.3 Italy Smoking Cessation Drugs Market
9.2.5.3.1 Italy Smoking Cessation Drugs Market by Product
9.2.5.3.2 Italy Smoking Cessation Drugs Market by Distribution
9.2.5.4 United Kingdom Smoking Cessation Drugs Market
9.2.5.4.1 United Kingdom Smoking Cessation Drugs Market by Product
9.2.5.4.2 United Kingdom Smoking Cessation Drugs Market by Distribution
9.2.5.5 Russia Smoking Cessation Drugs Market
9.2.5.5.1 Russia Smoking Cessation Drugs Market by Product
9.2.5.5.2 Russia Smoking Cessation Drugs Market by Distribution
9.2.5.6 Rest of Europe Smoking Cessation Drugs Market
9.2.5.6.1 Rest of Europe Smoking Cessation Drugs Market by Product
9.2.5.6.2 Rest of Europe Smoking Cessation Drugs Market by Distribution
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Smoking Cessation Drugs Market Overview
9.3.2 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.3.5 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Smoking Cessation Drugs Market
9.3.5.1.1 Australia Smoking Cessation Drugs Market by Product
9.3.5.1.2 Australia Smoking Cessation Drugs Market by Distribution
9.3.5.2 China Smoking Cessation Drugs Market
9.3.5.2.1 China Smoking Cessation Drugs Market by Product
9.3.5.2.2 China Smoking Cessation Drugs Market by Distribution
9.3.5.3 India Smoking Cessation Drugs Market
9.3.5.3.1 India Smoking Cessation Drugs Market by Product
9.3.5.3.2 India Smoking Cessation Drugs Market by Distribution
9.3.5.4 Japan Smoking Cessation Drugs Market
9.3.5.4.1 Japan Smoking Cessation Drugs Market by Product
9.3.5.4.2 Japan Smoking Cessation Drugs Market by Distribution
9.3.5.5 South Korea Smoking Cessation Drugs Market
9.3.5.5.1 South Korea Smoking Cessation Drugs Market by Product
9.3.5.5.2 South Korea Smoking Cessation Drugs Market by Distribution
9.3.5.6 Rest of Asia-Pacific Smoking Cessation Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Smoking Cessation Drugs Market by Product
9.3.5.6.2 Rest of Asia-Pacific Smoking Cessation Drugs Market by Distribution
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Smoking Cessation Drugs Market Overview
9.4.2 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.4.5 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Smoking Cessation Drugs Market
9.4.5.1.1 South Africa Smoking Cessation Drugs Market by Product
9.4.5.1.2 South Africa Smoking Cessation Drugs Market by Distribution
9.4.5.2 Saudi Arabia Smoking Cessation Drugs Market
9.4.5.2.1 Saudi Arabia Smoking Cessation Drugs Market by Product
9.4.5.2.2 Saudi Arabia Smoking Cessation Drugs Market by Distribution
9.4.5.3 U.A.E Smoking Cessation Drugs Market
9.4.5.3.1 U.A.E Smoking Cessation Drugs Market by Product
9.4.5.3.2 U.A.E Smoking Cessation Drugs Market by Distribution
9.4.5.4 Rest of Middle East and Africa Smoking Cessation Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Smoking Cessation Drugs Market by Product
9.4.5.4.2 Rest of Middle East and Africa Smoking Cessation Drugs Market by Distribution
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Smoking Cessation Drugs Market Overview
9.5.2 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis
9.5.3 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.5.5 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Smoking Cessation Drugs Market
9.5.5.1.1 Brazil Smoking Cessation Drugs Market by Product
9.5.5.1.2 Brazil Smoking Cessation Drugs Market by Distribution
9.5.5.2 Argentina Smoking Cessation Drugs Market
9.5.5.2.1 Argentina Smoking Cessation Drugs Market by Product
9.5.5.2.2 Argentina Smoking Cessation Drugs Market by Distribution
9.5.5.3 Rest of South and Central America Smoking Cessation Drugs Market
9.5.5.3.1 Rest of South and Central America Smoking Cessation Drugs Market by Product
9.5.5.3.2 Rest of South and Central America Smoking Cessation Drugs Market by Distribution
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMOKING CESSATION DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SMOKING CESSATION DRUGS MARKET, KEY COMPANY PROFILES
12.1. BRITISH AMERICAN TOBACCO PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DR.REDDY'S LABORATORIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FOMTEM VENTURES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GSK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IMPERIAL TOBACCO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. KIMREE TECHNOLOGY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NICOTEK LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NJOY INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Smoking Cessation Drugs Market - By Product
1.3.2 Smoking Cessation Drugs Market - By Distribution
1.3.3 Smoking Cessation Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SMOKING CESSATION DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SMOKING CESSATION DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SMOKING CESSATION DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. SMOKING CESSATION DRUGS - GLOBAL MARKET OVERVIEW
6.2. SMOKING CESSATION DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DRUG THERAPY
7.3.1. Overview
7.3.2. Drug therapy Market Forecast and Analysis
7.4. E-CIGARETTES
7.4.1. Overview
7.4.2. E-cigarettes Market Forecast and Analysis
7.5. NICOTINE REPLACEMENT THERAPIES
7.5.1. Overview
7.5.2. Nicotine replacement therapies Market Forecast and Analysis
7.6. AND NICOTINE SUBLINGUAL TABLETS.
7.6.1. Overview
7.6.2. and Nicotine Sublingual tablets. Market Forecast and Analysis
8. SMOKING CESSATION DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION
8.1. OVERVIEW
8.2. DISTRIBUTION MARKET FORECASTS AND ANALYSIS
8.3. DRUG STORES
8.3.1. Overview
8.3.2. Drug stores Market Forecast and Analysis
8.4. HOSPITAL PHARMACIES
8.4.1. Overview
8.4.2. Hospital pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online pharmacies Market Forecast and Analysis
8.6. AND RETAIL PHARMACIES.
8.6.1. Overview
8.6.2. and Retail pharmacies. Market Forecast and Analysis
9. SMOKING CESSATION DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Smoking Cessation Drugs Market Overview
9.1.2 North America Smoking Cessation Drugs Market Forecasts and Analysis
9.1.3 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.1.5 North America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Smoking Cessation Drugs Market
9.1.5.1.1 United States Smoking Cessation Drugs Market by Product
9.1.5.1.2 United States Smoking Cessation Drugs Market by Distribution
9.1.5.2 Canada Smoking Cessation Drugs Market
9.1.5.2.1 Canada Smoking Cessation Drugs Market by Product
9.1.5.2.2 Canada Smoking Cessation Drugs Market by Distribution
9.1.5.3 Mexico Smoking Cessation Drugs Market
9.1.5.3.1 Mexico Smoking Cessation Drugs Market by Product
9.1.5.3.2 Mexico Smoking Cessation Drugs Market by Distribution
9.2. EUROPE
9.2.1 Europe Smoking Cessation Drugs Market Overview
9.2.2 Europe Smoking Cessation Drugs Market Forecasts and Analysis
9.2.3 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.2.5 Europe Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Smoking Cessation Drugs Market
9.2.5.1.1 Germany Smoking Cessation Drugs Market by Product
9.2.5.1.2 Germany Smoking Cessation Drugs Market by Distribution
9.2.5.2 France Smoking Cessation Drugs Market
9.2.5.2.1 France Smoking Cessation Drugs Market by Product
9.2.5.2.2 France Smoking Cessation Drugs Market by Distribution
9.2.5.3 Italy Smoking Cessation Drugs Market
9.2.5.3.1 Italy Smoking Cessation Drugs Market by Product
9.2.5.3.2 Italy Smoking Cessation Drugs Market by Distribution
9.2.5.4 United Kingdom Smoking Cessation Drugs Market
9.2.5.4.1 United Kingdom Smoking Cessation Drugs Market by Product
9.2.5.4.2 United Kingdom Smoking Cessation Drugs Market by Distribution
9.2.5.5 Russia Smoking Cessation Drugs Market
9.2.5.5.1 Russia Smoking Cessation Drugs Market by Product
9.2.5.5.2 Russia Smoking Cessation Drugs Market by Distribution
9.2.5.6 Rest of Europe Smoking Cessation Drugs Market
9.2.5.6.1 Rest of Europe Smoking Cessation Drugs Market by Product
9.2.5.6.2 Rest of Europe Smoking Cessation Drugs Market by Distribution
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Smoking Cessation Drugs Market Overview
9.3.2 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.3.5 Asia-Pacific Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Smoking Cessation Drugs Market
9.3.5.1.1 Australia Smoking Cessation Drugs Market by Product
9.3.5.1.2 Australia Smoking Cessation Drugs Market by Distribution
9.3.5.2 China Smoking Cessation Drugs Market
9.3.5.2.1 China Smoking Cessation Drugs Market by Product
9.3.5.2.2 China Smoking Cessation Drugs Market by Distribution
9.3.5.3 India Smoking Cessation Drugs Market
9.3.5.3.1 India Smoking Cessation Drugs Market by Product
9.3.5.3.2 India Smoking Cessation Drugs Market by Distribution
9.3.5.4 Japan Smoking Cessation Drugs Market
9.3.5.4.1 Japan Smoking Cessation Drugs Market by Product
9.3.5.4.2 Japan Smoking Cessation Drugs Market by Distribution
9.3.5.5 South Korea Smoking Cessation Drugs Market
9.3.5.5.1 South Korea Smoking Cessation Drugs Market by Product
9.3.5.5.2 South Korea Smoking Cessation Drugs Market by Distribution
9.3.5.6 Rest of Asia-Pacific Smoking Cessation Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Smoking Cessation Drugs Market by Product
9.3.5.6.2 Rest of Asia-Pacific Smoking Cessation Drugs Market by Distribution
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Smoking Cessation Drugs Market Overview
9.4.2 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.4.5 Middle East and Africa Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Smoking Cessation Drugs Market
9.4.5.1.1 South Africa Smoking Cessation Drugs Market by Product
9.4.5.1.2 South Africa Smoking Cessation Drugs Market by Distribution
9.4.5.2 Saudi Arabia Smoking Cessation Drugs Market
9.4.5.2.1 Saudi Arabia Smoking Cessation Drugs Market by Product
9.4.5.2.2 Saudi Arabia Smoking Cessation Drugs Market by Distribution
9.4.5.3 U.A.E Smoking Cessation Drugs Market
9.4.5.3.1 U.A.E Smoking Cessation Drugs Market by Product
9.4.5.3.2 U.A.E Smoking Cessation Drugs Market by Distribution
9.4.5.4 Rest of Middle East and Africa Smoking Cessation Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Smoking Cessation Drugs Market by Product
9.4.5.4.2 Rest of Middle East and Africa Smoking Cessation Drugs Market by Distribution
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Smoking Cessation Drugs Market Overview
9.5.2 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis
9.5.3 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Distribution
9.5.5 South and Central America Smoking Cessation Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Smoking Cessation Drugs Market
9.5.5.1.1 Brazil Smoking Cessation Drugs Market by Product
9.5.5.1.2 Brazil Smoking Cessation Drugs Market by Distribution
9.5.5.2 Argentina Smoking Cessation Drugs Market
9.5.5.2.1 Argentina Smoking Cessation Drugs Market by Product
9.5.5.2.2 Argentina Smoking Cessation Drugs Market by Distribution
9.5.5.3 Rest of South and Central America Smoking Cessation Drugs Market
9.5.5.3.1 Rest of South and Central America Smoking Cessation Drugs Market by Product
9.5.5.3.2 Rest of South and Central America Smoking Cessation Drugs Market by Distribution
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SMOKING CESSATION DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SMOKING CESSATION DRUGS MARKET, KEY COMPANY PROFILES
12.1. BRITISH AMERICAN TOBACCO PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DR.REDDY'S LABORATORIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FOMTEM VENTURES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GSK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IMPERIAL TOBACCO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. KIMREE TECHNOLOGY
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NICOTEK LLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NJOY INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. British American Tobacco PLC
2. Dr. Reddy's Laboratories
3. Fontem Ventures
4. GlaxoSmithKline
5. GSK
6. Imperial Tobacco
7. Johnson & Johnson
8. Kimree Technology
9. Nicotek LLC
10. Njoy Inc.
1. British American Tobacco PLC
2. Dr. Reddy's Laboratories
3. Fontem Ventures
4. GlaxoSmithKline
5. GSK
6. Imperial Tobacco
7. Johnson & Johnson
8. Kimree Technology
9. Nicotek LLC
10. Njoy Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount